SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition-Reference-Cited by-同舟云学术

SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition

Published:2021-07 Issue: Volume:510 Page:93-104
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Liu Liguo,Li Yang,Cao Dongyan^ORCID,Qiu Shimei,Li Yongsheng,Jiang Chengkai,Bian Rui,Yang Yang,Li Lin,Li Xuechuan,Wang Ziyi,Ju Zheng,Zhang Yijian,Liu Yingbin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Biliary tract cancers: current knowledge, clinical candidates and future challenges;Tariq;Canc. Manag. Res.,2019

2. Gallbladder cancer;Baiu;Jama,2018

3. Overview of current targeted therapy in gallbladder cancer, Signal transduction and targeted therapy;Song,2020

4. Systemic therapy for gallbladder cancer;Javle;Chin. Clin. Oncol.,2019

5. Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer;Azizi;Chin. Clin. Oncol.,2019

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway;Cell Death & Disease;2024-09-11

2. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

3. CircEZH2 promotes gallbladder cancer progression and lipid metabolism reprogramming through the miR-556-5p/SCD1 axis;iScience;2024-08

4. SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics;Journal of Biochemical and Molecular Toxicology;2024-05-21

5. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern;Biomolecules and Biomedicine;2024-05-02